Financhill
Back

Telomir Pharmaceuticals Quote, Financials, Valuation and Earnings

Sell
39

TELO
Telomir Pharmaceuticals

Last Price:
6.01
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Telomir Pharmaceuticals Price Quote

$6.01
-0.17 (-2.78%)
(Updated: May 18, 2024 at 4:47 PM ET)

Telomir Pharmaceuticals Key Stats

Sell
39
Telomir Pharmaceuticals (TELO) is a Sell

Day range:
$6.02 - $6.51
52-week range:
$4.76 - $20.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
60.66%

Volume:
21.1K
Avg. volume:
45.2K
1-year change:
0%
Market cap:
$183M
Revenue:
$0
EPS:
$-0.66

How Much Does Telomir Pharmaceuticals Make?

Data Unavailable

Is Telomir Pharmaceuticals Growing As A Company?

Data Unavailable

Telomir Pharmaceuticals Stock Price Performance

What Is Telomir Pharmaceuticals 52-Week High & Low?

Telomir Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Telomir Pharmaceuticals?

Is Telomir Pharmaceuticals Cash Flow Positive?

  • What Is TELO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$5.1M
  • What Is Telomir Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8.3M
  • What Is Telomir Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Telomir Pharmaceuticals Return On Invested Capital

Data Unavailable

Telomir Pharmaceuticals Earnings Date & Stock Price

Telomir Pharmaceuticals Competitors

Telomir Pharmaceuticals Dividend Yield

Data Unavailable

Telomir Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many TELO shares are owned by institutional investors?
    51.3K TELO shares are owned by institutional investors
  • How many TELO shares are owned by insiders?
    1.7M TELO shares are owned by insiders